294 related articles for article (PubMed ID: 36798604)
1. Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use.
Perkins D; Ruffell SGD; Day K; Pinzon Rubiano D; Sarris J
Front Neurosci; 2022; 16():879221. PubMed ID: 36798604
[TBL] [Abstract][Full Text] [Related]
2. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids
Brito-da-Costa AM; Dias-da-Silva D; Gomes NGM; Dinis-Oliveira RJ; Madureira-Carvalho Á
Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114119
[TBL] [Abstract][Full Text] [Related]
3. Ayahuasca: A review of historical, pharmacological, and therapeutic aspects.
Ruffell SGD; Crosland-Wood M; Palmer R; Netzband N; Tsang W; Weiss B; Gandy S; Cowley-Court T; Halman A; McHerron D; Jong A; Kennedy T; White E; Perkins D; Terhune DB; Sarris J
PCN Rep; 2023 Dec; 2(4):e146. PubMed ID: 38868739
[TBL] [Abstract][Full Text] [Related]
4. Chemical Composition of Traditional and Analog Ayahuasca.
Kaasik H; Souza RCZ; Zandonadi FS; Tófoli LF; Sussulini A
J Psychoactive Drugs; 2021; 53(1):65-75. PubMed ID: 32896230
[TBL] [Abstract][Full Text] [Related]
5. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
Hamill J; Hallak J; Dursun SM; Baker G
Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
[TBL] [Abstract][Full Text] [Related]
7. Ayahuasca: What Healthcare Providers Need to Know.
Goldin D; Salani D
J Addict Nurs; 2021 Apr-Jun 01; 32(2):167-173. PubMed ID: 34060770
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.
Rossi GN; Guerra LTL; Baker GB; Dursun SM; Saiz JCB; Hallak JEC; Dos Santos RG
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358968
[TBL] [Abstract][Full Text] [Related]
9. Ayahuasca for the Treatment of Depression.
Palhano-Fontes F; Soares BL; Galvão-Coelho NL; Arcoverde E; Araujo DB
Curr Top Behav Neurosci; 2022; 56():113-124. PubMed ID: 34761362
[TBL] [Abstract][Full Text] [Related]
10. New Insights into the Chemical Composition of Ayahuasca.
Rodríguez L; López A; Moyna G; Seoane GA; Davyt D; Vázquez Á; Hernández G; Carrera I
ACS Omega; 2022 Apr; 7(14):12307-12317. PubMed ID: 35449956
[TBL] [Abstract][Full Text] [Related]
11. Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey.
Perkins D; Schubert V; Simonová H; Tófoli LF; Bouso JC; Horák M; Galvão-Coelho NL; Sarris J
Front Pharmacol; 2021; 12():623979. PubMed ID: 33967757
[TBL] [Abstract][Full Text] [Related]
12. Ayahuasca: Pharmacology, neuroscience and therapeutic potential.
Domínguez-Clavé E; Soler J; Elices M; Pascual JC; Álvarez E; de la Fuente Revenga M; Friedlander P; Feilding A; Riba J
Brain Res Bull; 2016 Sep; 126(Pt 1):89-101. PubMed ID: 26976063
[TBL] [Abstract][Full Text] [Related]
13. Ayahuasca: Uses, Phytochemical and Biological Activities.
Estrella-Parra EA; Almanza-Pérez JC; Alarcón-Aguilar FJ
Nat Prod Bioprospect; 2019 Aug; 9(4):251-265. PubMed ID: 31134518
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Cytotoxicity of Ayahuasca Beverages.
Simão AY; Gonçalves J; Gradillas A; García A; Restolho J; Fernández N; Rodilla JM; Barroso M; Duarte AP; Cristóvão AC; Gallardo E
Molecules; 2020 Nov; 25(23):. PubMed ID: 33260723
[TBL] [Abstract][Full Text] [Related]
15. Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease.
Katchborian-Neto A; Santos MFC; Vilas-Boas DF; Dos Santos EG; Veloso MP; Bueno PCP; Caldas IS; Soares MG; Dias DF; Chagas-Paula DA
Chem Biodivers; 2022 Oct; 19(10):e202200409. PubMed ID: 36163588
[TBL] [Abstract][Full Text] [Related]
16. The pharmacological interaction of compounds in ayahuasca: a systematic review.
Ruffell S; Netzband N; Bird C; Young AH; Juruena MF
Braz J Psychiatry; 2020; 42(6):646-656. PubMed ID: 32638916
[TBL] [Abstract][Full Text] [Related]
17. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.
Heise CW; Brooks DE
J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
Valle M; Maqueda AE; Rabella M; Rodríguez-Pujadas A; Antonijoan RM; Romero S; Alonso JF; Mañanas MÀ; Barker S; Friedlander P; Feilding A; Riba J
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1161-75. PubMed ID: 27039035
[TBL] [Abstract][Full Text] [Related]
19. Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca.
Shinozuka K; Tabaac BJ; Arenas A; Beutler BD; Cherian K; Evans VD; Fasano C; Muir OS
Am J Ther; 2024 Mar-Apr 01; 31(2):e112-e120. PubMed ID: 38518268
[TBL] [Abstract][Full Text] [Related]
20.
Malcolm BJ; Lee KC
Ment Health Clin; 2017 Jan; 7(1):39-45. PubMed ID: 29955496
[No Abstract] [Full Text] [Related]
[Next] [New Search]